Form CORRESP - Correspondence:
SEC Accession No. 0001213900-22-023618
Filing Date
2022-05-03
Accepted
2022-05-03 16:30:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5508
  Complete submission text file 0001213900-22-023618.txt   6635
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations